인쇄하기
취소

Novartis Korea, Dongwha expand cooperation

Published: 2011-07-04 06:57:00
Updated: 2011-07-04 06:57:00
Novartis Korea and Dongwha Pharmaceutical has recently agreed to further cooperation in over-the-counter (OTC) drugs field.

Both company signed an agreement to promote co-marketing of Novartis’s Lamisil, which had been marketed by Pacific Pharm.

Lamisil is commonly prescribed for the treatment of fingernail or toenail fungus, as well as ringworm of the scalp. The medication acts on certai...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.